04:49 AM EST, 11/13/2024 (MT Newswires) -- Guardian Pharmacy Services ( GRDN ) reported a Q3 loss of $2 per share.

Two analysts polled by Capital IQ expected earnings of $0.22.

The company completed its initial public offering in September.

Revenue for the quarter ended Sept. 30 was $314.4 million, up from $262.7 million a year earlier.

Three analysts surveyed by Capital IQ expected $303.2 million.

For 2024, revenue is projected to be $1.21 billion to $1.22 billion. Three analysts surveyed by Capital IQ expect $1.19 billion.